undamentalytics Newsletter
Sign in

Avantor, Inc. income statement

In fiscal 2025, Avantor, Inc. reported revenue of $6.55bn, down 3.4% on the year before, operating income of −$246m (a -3.8% margin) and net income of −$530m, or −$0.78 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue1,2475,8646,0406,3947,3867,5126,9676,7846,5526,636
Cost of revenue8154,0454,1204,3134,8834,9104,6034,5044,4134,539
Gross profit4331,8201,9212,0812,5032,6032,3642,2792,1392,096
Selling, general and administrative4501,4051,3691,3741,5311,4731,5071,6411,5961,604
Operating income−2104145527079721,1306961,085−246487
Interest expense201524440308217266285219170162
Income before tax−460−1144162753851411854−441316
Income tax−315−273−541801658914289−22
Net income−113−8738117573687321712−530337
Diluted EPS−$0.92−$0.90−$0.84$0.09$0.85$1.01$0.47$1.04−$0.78$0.50
Diluted shares (average)453m398m401m583m600m679m678m682m681m678m
EBITDA−1118189511,1021,3511,5361,0991,490164906

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: A vs AVTRAVTR vs ICLRAVTR vs WAT

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Avantor, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Avantor, Inc.